Pharmerica Corporation Company Profile (NYSE:PMC)

About Pharmerica Corporation

Pharmerica Corporation logoPharMerica Corporation is an institutional pharmacy services company. The Company services healthcare facilities, provides pharmacy management services to hospitals, provides specialty infusion services to patients outside a hospital setting and offers the national oncology pharmacy in the United States. It has three segments: institutional pharmacy, specialty infusion services and specialty oncology pharmacy. Its institutional pharmacy segment provides pharmacy products and services to residents and patients in skilled nursing facilities, nursing centers, assisted living facilities, hospitals and other long-term alternative care settings. Its specialty infusion services segment provides specialty infusion services focused on providing pharmaceutical products and clinical services to patients in client facilities, hospice and outside of hospital. Its specialty oncology pharmacy segment provides dispensing of oncology drugs, care management and other related services.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drug Stores
  • Sub-Industry: Health Care Distributors
  • Exchange: NYSE
  • Symbol: PMC
  • CUSIP: 71714F10
Key Metrics:
  • Previous Close: $26.75
  • 50 Day Moving Average: $25.49
  • 200 Day Moving Average: $25.35
  • 52-Week Range: $19.20 - $28.72
  • Trailing P/E Ratio: 23.06
  • Foreward P/E Ratio: 11.61
  • P/E Growth: 3.11
  • Market Cap: $778.76M
  • Outstanding Shares: 30,781,000
  • Beta: 1.1
Profitability:
  • Net Margins: 1.64%
  • Return on Equity: 10.40%
  • Return on Assets: 4.68%
Debt:
  • Debt-to-Equity Ratio: 0.71%
  • Current Ratio: 3.10%
  • Quick Ratio: 2.25%
Additional Links:
Companies Related to Pharmerica Corporation:

Analyst Ratings

Consensus Ratings for Pharmerica Corporation (NYSE:PMC) (?)
Ratings Breakdown: 1 Sell Rating, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.60)
Consensus Price Target: $30.00 (18.58% upside)

Analysts' Ratings History for Pharmerica Corporation (NYSE:PMC)
Show:
DateFirmActionRatingPrice TargetDetails
6/7/2016Bank of America CorpInitiated CoverageBuy$32.00View Rating Details
5/10/2016Barrington ResearchReiterated RatingOutperform$30.00 -> $34.00View Rating Details
3/15/2016Credit Suisse GroupInitiated CoverageOutperform$30.00View Rating Details
2/29/2016KeyCorpLower Price TargetOverweight$39.00 -> $32.00View Rating Details
2/29/2016Barclays PLCLower Price TargetUnderweight$27.00 -> $22.00View Rating Details
12/30/2015Cowen and CompanyReiterated RatingBuy$39.00 -> $41.00View Rating Details
(Data available from 2/25/2015 forward)

Earnings

Earnings History for Pharmerica Corporation (NYSE:PMC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/24/2017        
2/24/2017Q416$0.51$0.58$525.22 million$534.40 millionViewListenView Earnings Details
11/9/2016Q316$0.51$0.44$530.01 million$512.60 millionViewListenView Earnings Details
8/9/2016Q216$0.47$0.47$508.31 million$519.60 millionViewListenView Earnings Details
5/6/2016Q116$0.43$0.45$509.45 million$524.50 millionViewListenView Earnings Details
2/26/2016Q415$0.41$0.45$506.40 million$520.60 millionViewListenView Earnings Details
11/6/2015Q315$0.36$0.39$480.35 million$498.80 millionViewListenView Earnings Details
8/7/2015Q215$0.33$0.37$491.66 million$497.50 millionViewListenView Earnings Details
5/7/2015Q115$0.43$0.48$500.95 million$511.60 millionViewListenView Earnings Details
3/2/2015Q414$0.43$0.45$491.99 million$523.50 millionViewListenView Earnings Details
11/6/2014Q314$0.40$0.45$439.63 million$470.20 millionViewListenView Earnings Details
8/5/2014Q214$0.36$0.40$432.70 million$448.60 millionViewListenView Earnings Details
5/1/2014Q114$0.33$0.37$417.76 million$452.20 millionViewListenView Earnings Details
2/28/2014Q413$0.38$0.44$421.16 million$433.20 millionViewListenView Earnings Details
11/5/2013Q313$0.32$0.49$398.02 million$442.00 millionViewListenView Earnings Details
8/2/2013Q2 2013$0.34$0.44$414.15 million$458.50 millionViewListenView Earnings Details
5/1/2013Q1 2013$0.34$0.46$435.10 million$439.80 millionViewListenView Earnings Details
2/7/2013Q4 2012$0.29$0.12$432.43 million$433.20 millionViewListenView Earnings Details
11/1/2012Q312$0.30$0.33$446.36 million$442.00 millionViewN/AView Earnings Details
8/2/2012$0.30$0.32ViewN/AView Earnings Details
5/2/2012$0.27$0.30ViewN/AView Earnings Details
2/9/2012$0.21$0.27ViewN/AView Earnings Details
11/3/2011$0.20$0.31ViewN/AView Earnings Details
8/4/2011$0.20$0.32ViewN/AView Earnings Details
5/5/2011$0.20$0.21ViewN/AView Earnings Details
2/24/2011$0.17$0.16ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Pharmerica Corporation (NYSE:PMC)
Current Year EPS Consensus Estimate: $1.87 EPS
Next Year EPS Consensus Estimate: $2.18 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.36$0.48$0.41
Q2 20162$0.37$0.46$0.42
Q3 20162$0.49$0.50$0.50
Q4 20162$0.50$0.51$0.51
Q1 20171$0.51$0.51$0.51
Q2 20171$0.53$0.53$0.53
Q3 20171$0.57$0.57$0.57
Q4 20171$0.60$0.60$0.60
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Pharmerica Corporation (NYSE:PMC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Pharmerica Corporation (NYSE:PMC)
Insider Ownership Percentage: 5.04%
Institutional Ownership Percentage: 97.15%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/2/2015Robert A MckaySVPSell2,993$34.42$103,019.06View SEC Filing  
11/11/2015Mark LindemoenSVPSell3,790$34.71$131,550.90View SEC Filing  
6/16/2015Robert A MckaySVPSell7,000$32.75$229,250.00View SEC Filing  
6/3/2015Gregory S WeisharCEOSell104,150$32.63$3,398,414.50View SEC Filing  
6/1/2015Mark LindemoenSVPSell4,500$33.27$149,715.00View SEC Filing  
3/12/2015Berard TomassettiCAOSell3,344$26.44$88,415.36View SEC Filing  
3/12/2015Thomas A CanerisSVPSell7,495$26.52$198,767.40View SEC Filing  
3/6/2015Robert A MckaySVPSell20,000$26.74$534,800.00View SEC Filing  
8/8/2014Robert A OakleyDirectorSell8,399$26.55$222,993.45View SEC Filing  
5/13/2014Thomas CanerisSVPSell12,192$28.60$348,691.20View SEC Filing  
3/14/2014Gregory WeisharCEOSell60,000$26.27$1,576,200.00View SEC Filing  
3/13/2014Robert MckaySVPSell18,646$26.08$486,287.68View SEC Filing  
3/12/2014Berard TomassettiCAOSell3,812$25.22$96,138.64View SEC Filing  
3/6/2014Thomas CanerisSVPSell14,357$25.60$367,539.20View SEC Filing  
11/22/2013Thomas GerrityDirectorSell3,271$20.56$67,251.76View SEC Filing  
11/15/2013Berard TomassettiCAOSell4,097$20.55$84,193.35View SEC Filing  
5/30/2013Berard TomassettiCAOSell9,724$15.68$152,472.32View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Pharmerica Corporation (NYSE:PMC)
DateHeadline
biz.yahoo.com logoPharMerica Corp Earnings Call scheduled for 10:00 am ET today (NYSE:PMC)
us.rd.yahoo.com - February 25 at 1:28 AM
us.rd.yahoo.com logoEdited Transcript of PMC earnings conference call or presentation 24-Feb-17 3:00pm GMT (NYSE:PMC)
us.rd.yahoo.com - February 25 at 1:28 AM
finance.yahoo.com logoPharMerica beats 4Q profit forecasts (NYSE:PMC)
finance.yahoo.com - February 24 at 8:27 PM
seekingalpha.com logoPharMerica's (PMC) CEO Greg Weishar on Q4 2016 Results - Earnings Call Transcript (NYSE:PMC)
seekingalpha.com - February 24 at 8:27 PM
News IconWill PharMerica Corporation’s (PMC) Earnings Grow In Next 12 Months? (NYSE:PMC)
simplywall.st - February 24 at 8:27 PM
bizjournals.com logoPharmerica increases goal for merger revenue in Q4 earnings call (NYSE:PMC)
www.bizjournals.com - February 24 at 8:27 PM
News IconFollowing the Numbers for This Stock: PharMerica Corp (PMC) - Providence Standard (NYSE:PMC)
providencestandard.com - February 24 at 8:29 AM
News IconStock Buzz on Pharmerica Corporation (NYSE:PMC): Can They Meet the Earnings Target of $0.51 - Winfield Review (NYSE:PMC)
winfieldreview.com - February 24 at 8:29 AM
biz.yahoo.com logoQ4 2016 PharMerica Corp Earnings Release - Before Market Open (NYSE:PMC)
biz.yahoo.com - February 24 at 8:28 AM
finance.yahoo.com logoPharMerica Reports Fourth Quarter and Full Year 2016 Results (NYSE:PMC)
finance.yahoo.com - February 24 at 8:28 AM
News IconStock on Radar: Pharmerica Corporation (NYSE:PMC) Price Target Update - Rockville Register (NYSE:PMC)
rockvilleregister.com - February 20 at 6:31 PM
capitalcube.com logoPharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : February 14, 2017 (NYSE:PMC)
www.capitalcube.com - February 14 at 11:35 PM
News IconWhat are Research Firms Saying About Pharmerica Corporation (NYSE:PMC)? - Aiken Advocate (NYSE:PMC)
aikenadvocate.com - February 10 at 2:37 AM
realistinvestor.com logoPharmerica Corporation (NYSE:PMC) Accounts Payable Is $73 For The Quarter Ended 2016-09-30 - RealistInvestor.com (NYSE:PMC)
www.realistinvestor.com - February 7 at 8:51 AM
finance.yahoo.com logoPharMerica Corporation Announces Fourth Quarter and Year End 2016 Earnings Call and Webcast (NYSE:PMC)
finance.yahoo.com - February 3 at 8:08 PM
News IconHealth care notes: Ex-Healthways CFO lands at Kentucky company (NYSE:PMC)
www.nashvillepost.com - February 2 at 8:18 PM
bizjournals.com logoPharMerica hires a new top executive (NYSE:PMC)
www.bizjournals.com - February 1 at 9:56 PM
streetinsider.com logoPharmerica (PMC) Names Robert Dries as CFO (NYSE:PMC)
www.streetinsider.com - February 1 at 9:56 PM
us.rd.yahoo.com logoPharMerica Appoints Robert E. Dries as Executive Vice President and Chief Financial Officer (NYSE:PMC)
us.rd.yahoo.com - February 1 at 9:56 PM
us.rd.yahoo.com logo9:01 am PharMerica appoints Robert E. Dries as Chief Financial Officer effective January 31 (NYSE:PMC)
us.rd.yahoo.com - February 1 at 9:56 PM
News IconEarnings Parade Rolls On, What Are Analysts Saying About Pharmerica Corporation (NYSE:PMC)? - Wall Street Beacon (NYSE:PMC)
wsbeacon.com - January 31 at 12:57 AM
realistinvestor.com logoDeferred Tax Assets Of Pharmerica Corporation (NYSE:PMC) At $26.3 Millions - RealistInvestor.com (NYSE:PMC)
www.realistinvestor.com - January 30 at 7:56 PM
News IconMA Watch on Shares of PharMerica Corporation (PMC) - Market Point (NYSE:PMC)
mtptnews.com - January 30 at 7:56 PM
News IconConsensus Take: Pharmerica Corporation (NYSE:PMC) Earnings & Ratings Watch - Aiken Advocate (NYSE:PMC)
aikenadvocate.com - January 27 at 1:02 AM
News IconRelative Strength Index Check on PharMerica Corporation (PMC) - Market Point (NYSE:PMC)
mtptnews.com - January 27 at 1:02 AM
News IconShares in Focus: PharMerica Corporation (NYSE:PMC) - The Tribune (NYSE:PMC)
lakecitytribune.com - January 26 at 1:09 AM
capitalcube.com logoPharMerica Corp. – Value Analysis (NYSE:PMC) : January 24, 2017 (NYSE:PMC)
www.capitalcube.com - January 24 at 8:03 PM
realistinvestor.com logoEPS Projection Of Pharmerica Corporation (NYSE:PMC) At $0.6 - RealistInvestor.com (NYSE:PMC)
www.realistinvestor.com - January 24 at 8:32 AM
News IconEarnings in Full Force, Analysts Take Aim at Pharmerica Corporation (NYSE:PMC) - Wall Street Beacon (NYSE:PMC)
wsbeacon.com - January 24 at 8:32 AM
capitalcube.com logoPharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : January 23, 2017 (NYSE:PMC)
www.capitalcube.com - January 23 at 9:24 AM
News IconWill The Needle Move For Pharmerica Corporation (NYSE:PMC) Shares This Earnings Season? - Wall Street Beacon (NYSE:PMC)
wsbeacon.com - January 18 at 8:33 AM
News IconPharmerica Corp PMC Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NYSE:PMC)
www.bioportfolio.com - January 17 at 7:37 PM
News IconGearing Up For a Bull Run? Analysts Weigh in on Pharmerica Corporation (NYSE:PMC) - Wall Street Beacon (NYSE:PMC)
wsbeacon.com - January 14 at 1:33 AM
realistinvestor.com logoPharmerica Corporation (NYSE:PMC) EPS Estimate At $0.6 - RealistInvestor.com (NYSE:PMC)
www.realistinvestor.com - January 10 at 8:10 PM
finance.yahoo.com logoPharMerica Announces Expansion of Existing Credit Facility, Increasing Borrowing Capacity by $150 Million (NYSE:PMC)
finance.yahoo.com - December 15 at 8:31 PM
finance.yahoo.com logo4:20 pm PharMerica amends its existing credit agreement with Bank of America to increase the Co's borrowing capacity by approx. $150 million; (NYSE:PMC)
finance.yahoo.com - December 15 at 8:31 PM
biz.yahoo.com logoPHARMERICA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial S (NYSE:PMC)
biz.yahoo.com - December 15 at 8:31 PM
capitalcube.com logoETFs with exposure to PharMerica Corp. : December 9, 2016 (NYSE:PMC)
www.capitalcube.com - December 9 at 7:13 PM
capitalcube.com logoPharMerica Corp. breached its 50 day moving average in a Bullish Manner : PMC-US : December 9, 2016 (NYSE:PMC)
www.capitalcube.com - December 9 at 8:22 AM
News IconChecking the Levels on Shares of PharMerica Corporation (NYSE:PMC) - The Business Journal (NYSE:PMC)
belmontbusinessjournal.com - November 24 at 6:55 PM
News IconADX in View on Shares of PharMerica Corporation (PMC) - StockTalk Daily (NYSE:PMC)
stocktalkdaily.com - November 23 at 7:09 PM
News IconPrice Index Watch on Shares of PharMerica Corporation (NYSE:PMC) - The Business Journal (NYSE:PMC)
belmontbusinessjournal.com - November 22 at 7:03 PM
News IconPharmerica Corporation PMC Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250 (NYSE:PMC)
www.bioportfolio.com - November 19 at 6:54 PM
News IconStock in Focus: PharMerica Corporation (NYSE:PMC) - Marion Business Daily (NYSE:PMC)
marionbusinessdaily.com - November 18 at 6:29 PM
capitalcube.com logoPharMerica Corp. :PMC-US: Earnings Analysis: Q3, 2016 By the Numbers : November 18, 2016 (NYSE:PMC)
www.capitalcube.com - November 18 at 6:29 PM
finance.yahoo.com logoPHARMERICA CORP Financials (NYSE:PMC)
finance.yahoo.com - November 17 at 6:35 PM
News IconSell-side Taking Aim at Shares of Pharmerica Corporation (NYSE:PMC) - CSZ News (NYSE:PMC)
cincysportszone.com - November 17 at 10:49 AM
News IconChart Inspection on Shares of PharMerica Corporation (PMC) - StockTalk Daily (NYSE:PMC)
stocktalkdaily.com - November 17 at 10:49 AM
News IconWhat The Charts Are Saying About PharMerica Corporation (NYSE:PMC) - Wall Street Lion (NYSE:PMC)
wslnews.com - November 16 at 7:09 PM
stocksdaily.net logoPharmerica Corporation (NYSE:PMC) Yearly EPS Projection At $2.1 - Stocks Daily (NYSE:PMC)
www.stocksdaily.net - November 14 at 7:07 PM

Social

What is Pharmerica Corporation's stock symbol?

Pharmerica Corporation trades on the New York Stock Exchange (NYSE) under the ticker symbol "PMC."

Where is Pharmerica Corporation's stock going? Where will Pharmerica Corporation's stock price be in 2017?

5 brokerages have issued twelve-month price objectives for Pharmerica Corporation's shares. Their forecasts range from $22.00 to $34.00. On average, they anticipate Pharmerica Corporation's stock price to reach $30.00 in the next twelve months.

When will Pharmerica Corporation announce their earnings?

Pharmerica Corporation is scheduled to release their next quarterly earnings announcement on Friday, February, 24th 2017.

Who owns Pharmerica Corporation stock?

Pharmerica Corporation's stock is owned by a number of of retail and institutional investors. Top institutional shareholders include Dimensional Fund Advisors LP (8.44%), FMR LLC (7.44%), State Street Corp (2.46%), Discovery Group I LLC (1.69%), Loomis Sayles & Co. L P (1.57%) and Systematic Financial Management LP (1.45%). Company insiders that own Pharmerica Corporation stock include Berard Tomassetti, Gregory S Weishar, Mark Lindemoen, Robert A Mckay and Thomas A Caneris.

Who sold Pharmerica Corporation stock? Who is selling Pharmerica Corporation stock?

Pharmerica Corporation's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Systematic Financial Management LP, Putnam Investments LLC, Thrivent Financial for Lutherans, Allianz Asset Management AG, Dimensional Fund Advisors LP, AQR Capital Management LLC and Century Capital Management LLC.

Who bought Pharmerica Corporation stock? Who is buying Pharmerica Corporation stock?

Pharmerica Corporation's stock was purchased by a variety of institutional investors in the last quarter, including Discovery Group I LLC, Guggenheim Capital LLC, State Street Corp, Russell Investments Group Ltd., A.R.T. Advisors LLC, Oxford Asset Management, Cornercap Investment Counsel Inc. and Tudor Investment Corp Et Al.

How do I buy Pharmerica Corporation stock?

Shares of Pharmerica Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Pharmerica Corporation stock cost?

One share of Pharmerica Corporation stock can currently be purchased for approximately $25.30.

Pharmerica Corporation (NYSE:PMC) Chart for Saturday, February, 25, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Pharmerica Corporation (NYSE:PMC)

Earnings History Chart

Earnings by Quarter for Pharmerica Corporation (NYSE:PMC)

Dividend History Chart

Dividend Payments by Quarter for Pharmerica Corporation (NYSE:PMC)

Last Updated on 2/25/2017 by MarketBeat.com Staff